Versant Capital Management’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.28K | Buy |
1,643
+934
| +132% | +$4.71K | ﹤0.01% | 1972 |
|
|
2025
Q1 | $4.59K | Buy |
+709
| New | +$4.59K | ﹤0.01% | 2057 |
|
|
2024
Q4 | – | Sell |
-391
| Closed | -$2.93K | – | 2436 |
|
|
2024
Q3 | $2.93K | Sell |
391
-1,763
| -82% | -$13.2K | ﹤0.01% | 1459 |
|
|
2024
Q2 | $19.2K | Buy |
2,154
+1,895
| +732% | +$16.9K | ﹤0.01% | 737 |
|
|
2024
Q1 | $2.62K | Buy |
259
+38
| +17% | +$385 | ﹤0.01% | 1263 |
|
|
2023
Q4 | $2.22K | Buy |
221
+23
| +12% | +$231 | ﹤0.01% | 1255 |
|
|
2023
Q3 | $1.86K | Buy |
198
+84
| +74% | +$787 | ﹤0.01% | 1336 |
|
|
2023
Q2 | $2.8K | Buy |
114
+21
| +23% | +$515 | ﹤0.01% | 1248 |
|
|
2023
Q1 | $2.16K | Hold |
93
| – | – | ﹤0.01% | 1258 |
|
|
2022
Q4 | $2.35K | Sell |
93
-15
| -14% | -$380 | ﹤0.01% | 1095 |
|
|
2022
Q3 | $2K | Buy |
108
+71
| +192% | +$1.32K | ﹤0.01% | 1138 |
|
|
2022
Q2 | $1K | Buy |
37
+25
| +208% | +$676 | ﹤0.01% | 1373 |
|
|
2022
Q1 | $0 | Buy |
+12
| New | – | ﹤0.01% | 1648 |
|